P53 in survival, death and metabolic health: a lifeguard with a licence to kill.
The DOI matches its Crossref record; 177 of the 177 references it cites were found in a registry or an index.
Abstract
The function of p53 as a tumour suppressor has been attributed to its ability to promote cell death or permanently inhibit cell proliferation. However, in recent years, it has become clear that p53 can also contribute to cell survival. p53 regulates various metabolic pathways, helping to balance glycolysis and oxidative phosphorylation, limiting the production of reactive oxygen species, and contributing to the ability of cells to adapt to and survive mild metabolic stresses. Although these activities may be integrated into the tumour suppressive functions of p53, deregulation of some elements of the p53-induced response might also provide tumours with a survival advantage.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Autophagy is another cellular program that is triggered by cell stress and p53.195, 208”
From Census and evaluation of p53 target genes (2017) · cites this paper as [195]
In the citing paper
“Target genes directly regulated by p53 participate in multiple metabolic pathways.194, 195”
From Census and evaluation of p53 target genes (2017) · cites this paper as [195]
In the citing paper
“Additional signals and persistent stress can lead to sustained expression of p53 and activation of p16INK4A contributing to a long lasting cell cycle arrest (Sharpless and DePinho, 2006; Salama et al., 2014; Kruiswijk et al., 2015).”
From Mechanisms of Cellular Senescence: Cell Cycle Arrest and Senescence Associated Secretory Phenotype (2021) · cites this paper as Kruiswijk et al., 2015
In the citing paper
“Second, most types of cellular stress are able to induce a p53 response, but they all use different mechanisms to activate the protein [65, 66, 67].”
From The TP53 tumor suppressor gene: From molecular biology to clinical investigations (2025) · cites this paper as [67]
In the citing paper
“p53 also promotes fatty acid oxidation by activating the expression of CPT1C, MCD and PANK1.107”
From Targeting p53 pathways: mechanisms, structures, and advances in therapy (2023) · cites this paper as [107]
Citations
Cites
Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation
Vander Heiden, M. G., Cantley, L. C., & Thompson, C. B. (2009) · Science · doi:10.1126/science.1160809 · Cited by 16,197
WAF1, a potential mediator of p53 tumor suppression
El-Deiry, W. S., Tokino, T., Velculescu, V. E., Levy, D. B., Parsons, R., Trent, J. M., Lin, D., Mercer, W. E., Kinzler, K. W., & Vogelstein, B. (1993) · Cell · doi:10.1016/0092-8674(93)90500-p · Cited by 8,321
Autophagy: Renovation of Cells and Tissues
Mizushima, N., & Komatsu, M. (2011) · Cell · doi:10.1016/j.cell.2011.10.026 · Cited by 6,418
Mdm2 promotes the rapid degradation of p53
Haupt, Y., Maya, R., Kazaz, A., & Oren, M. (1997) · Nature · doi:10.1038/387296a0 · Cited by 4,506
Modulation of oxidative stress as an anticancer strategy
Gorrini, C., Harris, I. S., & Mak, T. W. (2013) · Nature Reviews Drug Discovery · doi:10.1038/nrd4002 · Cited by 3,579
Ferroptosis as a p53-mediated activity during tumour suppression
Jiang, L., Kon, N., Li, T., Wang, S.-J., Su, T., Hibshoosh, H., Baer, R., & Gu, W. (2015) · Nature · doi:10.1038/nature14344 · Cited by 3,398
Induction of autophagy and inhibition of tumorigenesis by beclin 1
Liang, X. H., Jackson, S., Seaman, M., Brown, K., Kempkes, B., Hibshoosh, H., & Levine, B. (1999) · Nature · doi:10.1038/45257 · Cited by 3,347
Regulation of p53 stability by Mdm2
Kubbutat, M. H. G., Jones, S. N., & Vousden, K. H. (1997) · Nature · doi:10.1038/387299a0 · Cited by 3,312
Self-citationBlinded by the Light: The Growing Complexity of p53
Vousden, K. H., & Prives, C. (2009) · Cell · doi:10.1016/j.cell.2009.04.037 · Cited by 3,163
Self-citationA model for p53-induced apoptosis
Polyak, K., Xia, Y., Zweier, J. L., Kinzler, K. W., & Vogelstein, B. (1997) · Nature · doi:10.1038/38525 · Cited by 2,500
Cited by
Items 301–400 of 1,000
Han, A., Purwin, T. J., Bechtel, N., Liao, C., Chua, V. Y. L., Seifert, E. L., Sato, T., Schug, Z. T., Speicher, D. W., Harbour, J. W., et al. (2020) · Oncogene · doi:10.1038/s41388-020-01554-y · Cited by 52
Gain of Function (GOF) Mutant p53 in Cancer—Current Therapeutic Approaches
Roszkowska, K. A., Piecuch, A., Sady, M., Gajewski, Z., & Flis, S. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232113287 · Cited by 51
An Integrated Global Analysis of Compartmentalized HRAS Signaling
Santra, T., Herrero, A., Rodríguez, J., von Kriegsheim, A., Iglesias-Martinez, L. F., Schwarzl, T., Higgins, D. G., Aye, T., Heck, A. J. R., Calvo, F., et al. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.02.038 · Cited by 49
“Similarly, TP53 is usually linked to promotion of apoptosis but also can protect cells when the apoptotic stress is mild (Kruiswijk et al., 2015).”
BackgroundMolecular pathways in the development of HPV-induced cervical cancer
Bonab, F. R., Baghbanzadeh, A., Ghaseminia, M., Bolandi, N., Mokhtarzadeh, A., Amini, M., Dadashzadeh, K., Hajiasgharzadeh, K., Baradaran, B., & Baghi, H. B. (2021) · EXCLI journal · doi:10.17179/excli2021-3365 · Cited by 67
“E6 has 160 amino acids, contributes to P53 inhibition through ubiquitination (Kruiswijk et al., 2015; Paek et al., 2016).”
BackgroundClass I histone deacetylases regulate p53/NF-κB crosstalk in cancer cells
Schäfer, C., Göder, A., Beyer, M., Kiweler, N., Mahendrarajah, N., Rauch, A., Nikolova, T., Stojanovic, N., Wieczorek, M., Reich, T. R., et al. (2016) · Cellular Signalling · doi:10.1016/j.cellsig.2016.11.002 · Cited by 49
Mendez, L., Posey, R. R., & Pandolfi, P. P. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2019.01162 · Cited by 53
Revisiting prostate cancer metabolism: From metabolites to disease and therapy
Cardoso, H. J., Carvalho, T. M. A., Fonseca, L. R. S., Figueira, M. I., Vaz, C. V., & Socorro, S. (2020) · Medicinal Research Reviews · doi:10.1002/med.21766 · Cited by 54
“The most frequently mutated tumor suppressor gene in human cancers, the p53, 193 also was reported to play an important role in the regulation of metabolic pathways in cancer cells.(194,195) The existent knowledge places p53 in the regulation of glycolysis.”
BackgroundChen, C., Fu, G., Guo, Q., Xue, S., & Luo, S. (2022) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2022.09.087 · Cited by 45
Ramalingam, V., Revathidevi, S., Krishnamoorthy, V., Ravikumar, V., & Rajaram, R. (2016) · Tumor Biology · doi:10.1007/s13277-016-4947-8 · Cited by 45
“has been found in many tumors with less survival rate [6].”
BackgroundAldonza, M. B. D., Son, Y. S., Sung, H.-J., Ahn, J., Choi, Y. J., Kim, Y., Cho, S., & Cho, J. (2017) · Oncotarget · doi:10.18632/oncotarget.17069 · Cited by 45
“This finding relates PON1 activity to extrinsic ligand-induced cell death since glycolytic shifts mediate the binding of TNF ligands and TRAIL to their respective death receptors [20].”
BackgroundGiacomelli, C., Daniele, S., Natali, L., Iofrida, C., Flamini, G., Braca, A., Trincavelli, M. L., & Martini, C. (2017) · Scientific Reports · doi:10.1038/s41598-017-15360-2 · Cited by 45
Pleiotropic Role of p53 in Injury and Liver Regeneration after Acetaminophen Overdose
Borude, P., Bhushan, B., Gunewardena, S., Akakpo, J., Jaeschke, H., & Apte, U. (2018) · The American Journal of Pathology · doi:10.1016/j.ajpath.2018.03.006 · Cited by 46
“2,3,35 It is plausible that reduced autophagy may have resulted in prolonged adduct accumulation in liver, leading to delayed serum secretion and progression of injury in p53KO mice.”
BackgroundGjorgjieva, M., Caldéraro, J., Monteillet, L., Silva, M., Raffin, M., Brevet, M., Romestaing, C., Roussel, D., Zucman‐Rossi, J., Mithieux, G., et al. (2018) · Journal of Hepatology · doi:10.1016/j.jhep.2018.07.017 · Cited by 53
Extracellular Vesicles: Messengers of p53 in Tumor–Stroma Communication and Cancer Metastasis
Pavlakis, E., Neumann, M. M., & Stiewe, T. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21249648 · Cited by 47
“It is placed at the center of a multifaceted network comprising a diverse array of p53-activating inputs and numerous outgoing effector pathways, that range from protective antioxidant and DNA repair activities to the induction of transient cell cycle arrest, permanent cell cycle withdrawal by senescence and the induc…”
BackgroundZhang, P., Kitchen-Smith, I., Xiong, L., Stracquadanio, G., Brown, K., Richter, P., Wallace, M. D., Bond, E. E., Sahgal, N., Moore, S., et al. (2021) · Cancer Research · doi:10.1158/0008-5472.can-20-0177 · Cited by 48
“Activation of these genes in tumors retaining wtTP53 provide a survival advantage (49).”
BackgroundBekhet, O. H., & Eid, M. E. (2021) · Translational Cancer Research · doi:10.21037/tcr-21-629 · Cited by 47
“The p53 tumor suppressor gene is found to play a regulatory role in ROS accumulation by inducing the expression of several antioxidant genes like SOD2, glutathione peroxidase 1 (GPX1), and catalase (CAT), thus when p53 is exposed to mutation or loss of function, ROS accumulation is observed in more than 50% of human c…”
BackgroundMach, N., Ramayo‐Caldas, Y., Clark, A. P., Moroldo, M., Robert, C., Barrey, É., Martí, J. M. L., & Moyec, L. L. (2017) · BMC Genomics · doi:10.1186/s12864-017-3571-3 · Cited by 48
“[62] with permission from Nature publishing group (License number: 3902041297601) Mach et al.”
Acute Endurance Exercise Induces Nuclear p53 Abundance in Human Skeletal Muscle
Tachtsis, B., Smiles, W. J., Lane, S. C., Hawley, J. A., & Camera, D. M. (2016) · Frontiers in Physiology · doi:10.3389/fphys.2016.00144 · Cited by 45
Losenkova, K., Zuccarini, M., Helenius, M., Jacquemet, G., Gerasimovskaya, E. V., Tallgrén, C., Jalkanen, S., & Yegutkin, G. G. (2018) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2018.03.001 · Cited by 81
The crisscross between p53 and metabolism in cancer
Mao, Y., & Jiang, P. (2023) · Acta Biochimica et Biophysica Sinica · doi:10.3724/abbs.2023109 · Cited by 47
“regulation of p53 and glycolysis has been systematically reviewed [19], we will not discuss it here.”
BackgroundEnvironmental carcinogenesis and pH homeostasis: Not only a matter of dysregulated metabolism
Hardonnière, K., Laurence Therese, H. U. C., Sergent, O., Holme, J. A., & Lagadic‐Gossmann, D. (2017) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2017.01.001 · Cited by 49
“However, p53 is generally given as limiting glycolysis and improving oxidative phosphorylation [226].”
BackgroundMicroRNAs as Key Effectors in the p53 Network
Goeman, F., Strano, S., & Blandino, G. (2017) · International review of cytology · doi:10.1016/bs.ircmb.2017.04.003 · Cited by 47
The Nonstructural NS1 Protein of Influenza Viruses Modulates TP53 Splicing through Host Factor CPSF4
Dubois, J., Traversier, A., Julien, T., Padey, B., Lina, B., Bourdon, J., Marcel, V., Boivin, G., Rosa‐Calatrava, M., & Terrier, O. (2019) · Journal of Virology · doi:10.1128/jvi.02168-18 · Cited by 45
“activated in response to various cellular stresses and that regulates a broad range of biological processes, such as cell cycle arrest, apoptosis, and senescence (31, 32).”
BackgroundGhazi, T., Nagiah, S., & Chuturgoon, A. A. (2020) · Epigenetics · doi:10.1080/15592294.2020.1788324 · Cited by 46
“Once activated, p53 recruits core transcriptional machinery to its target promoters, enabling the transcription of genes, with cellular outcomes such as cell cycle arrest and apoptosis [28,29].”
BackgroundTp53 Suppression Promotes Cardiomyocyte Proliferation during Zebrafish Heart Regeneration
Shoffner, A. R., Cigliola, V., Lee, N., Ou, J., & Poss, K. D. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.108089 · Cited by 47
“Tp53 is a highly conserved transcription factor with critical roles in a variety of cell processes including cell cycle regulation, DNA repair, apoptosis, and senescence (Belyi et al., 2010; Berghmans et al., 2005; Fridman and Lowe, 2003; Hafner et al., 2019; Kruiswijk et al., 2015; Vousden and Lu, 2002).”
Wang, L., Yan, K., He, X., Zhu, H., Song, J., Chen, S., Cai, S., Zhao, Y., & Wang, L. (2020) · Journal of Cancer · doi:10.7150/jca.48983 · Cited by 46
Melatonin: Regulation of Biomolecular Condensates in Neurodegenerative Disorders
Loh, D., & Reiter, R. J. (2021) · Antioxidants · doi:10.3390/antiox10091483 · Cited by 45
Cardiotoxicity of Cancer Treatments: Focus on Anthracycline Cardiomyopathy
Nishi, M., Wang, P., & Hwang, P. M. (2021) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.121.316697 · Cited by 53
Huang, Y., Chen, X., Wang, C., Deng, J., Zuo, Z., Wu, H., Xiong, J., Wu, X., Lu, H., Hao, Q., et al. (2023) · Cell Reports · doi:10.1016/j.celrep.2023.113426 · Cited by 45
Noncoding RNAs in Regulation of Cancer Metabolic Reprogramming
Yang, D., Sun, L., Li, Z., & Gao, P. (2016) · Advances in experimental medicine and biology · doi:10.1007/978-981-10-1498-7_7 · Cited by 43
Regulation of Signal Transduction by DJ-1
Oh, S. E., & Mouradian, M. M. (2017) · Advances in experimental medicine and biology · doi:10.1007/978-981-10-6583-5_8 · Cited by 49
TP53 is required for BECN1- and ATG5-dependent cell death induced by sphingosine kinase 1 inhibition
Lima, S., Takabe, K., Newton, J. C., Saurabh, K., Young, M. M., Leopoldino, A. M., Hait, N. C., Roberts, J. L., Wang, H., Dent, P., et al. (2018) · Autophagy · doi:10.1080/15548627.2018.1429875 · Cited by 46
Bourdens, M., Jeanson, Y., Taurand, M., Juin, N., Carrière, A., Clément, F., Casteilla, L., Bulteau, A., & Planat‐Benard, V. (2019) · Scientific Reports · doi:10.1038/s41598-019-45191-2 · Cited by 52
A thiol-bound drug reservoir enhances APR-246-induced mutant p53 tumor cell death
Ceder, S., Eriksson, S. E., Cheteh, E. H., Dawar, S., Corrales Benitez, M., Bykov, V. J. N., Fujihara, K. M., Grandin, M., Li, X., Ramm, S., et al. (2021) · EMBO Molecular Medicine · doi:10.15252/emmm.201910852 · Cited by 41
“Since p53 has a redox regulatory role (Sablina et al, 2005; Kruiswijk et al, 2015) and its activity is dependent on the redox environment (Hainaut & Milner, 1993; Ueno et al, 1999), separating APR-246 anti-tumor activities mediated 1 Department of Oncology-Pathology, Karolinska Institutet,…”
BackgroundKinetic analysis of multistep USP7 mechanism shows critical role for target protein in activity.
Kim, R. Q., Geurink, P. P., Mulder, M. P. C., Fish, A., Ekkebus, R., El Oualid, F., van Dijk, W. J., van Dalen, D., Ovaa, H., van Ingen, H., et al. (2019) · Nature Communications · doi:10.1038/s41467-018-08231-5 · Cited by 41
Targeting USP2 regulation of VPRBP-mediated degradation of p53 and PD-L1 for cancer therapy
Yi, J., Tavana, O., Li, H., Wang, D., Baer, R. J., & Gu, W. J. (2023) · Nature Communications · doi:10.1038/s41467-023-37617-3 · Cited by 48
The role of metabolic reprogramming in liver cancer and its clinical perspectives
Lu, M., Wu, Y., Xia, M., & Zhang, Y. (2024) · Frontiers in Oncology · doi:10.3389/fonc.2024.1454161 · Cited by 46
Microenvironmental Effects of Cell Death in Malignant Disease
Gregory, C. D., Ford, C. A., & Voss, J. J. L. P. (2016) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-39406-0_3 · Cited by 43
Therapy Effects of Wogonin on Ovarian Cancer Cells
Ruibin, J., Jin, B., Wan, D., Chihong, Z., Jianguo, F., & Gu, L. (2017) · BioMed Research International · doi:10.1155/2017/9381513 · Cited by 41
“These proteins are valuable therapeutic targets for cancer treatment [37, 38].”
BackgroundQiu, X., Guo, H., Yang, J., Ji, Y., Wu, C., & Chen, X. (2018) · Scientific Reports · doi:10.1038/s41598-018-19828-7 · Cited by 41
Leslie, P. L., Franklin, D. A., Liu, Y. U., & Zhang, Y. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.07.010 · Cited by 43
“Thus, although previous studies have explored p53 signaling in either a pro-survival or a pro-apoptotic context, the effect of p53 activation depends on multiple factors, including cell type and the stressors to which the cell is exposed (Kruiswijk et al., 2015).”
BackgroundMetformin: Metabolic Rewiring Faces Tumor Heterogeneity
Cioce, M., Pulito, C., Strano, S., Blandino, G., & Fazio, V. M. (2020) · Cells · doi:10.3390/cells9112439 · Cited by 42
“Collectively, wild-type p53 inhibits the shift from oxidative phosphorylation to glycolysis [116,117], promotes fatty acid oxidation while preventing lipid accumulation in cancer cells [118] and does so by modulating hundreds of targets [119].”
BackgroundmTORC1 beyond anabolic metabolism: Regulation of cell death
Zhu, J., Wang, H., & Jiang, X. (2022) · The Journal of Cell Biology · doi:10.1083/jcb.202208103 · Cited by 47
“Over the past two decades, it has been demonstrated that regulation of cellular metabolism is another critical component of the p53 tumor suppressive function (Kruiswijk et al., 2015).”
BackgroundInfluentialAndersen, H. B., Ialchina, R., Pedersen, S. F., & Czaplińska, D. (2021) · Cancer and Metastasis Reviews · doi:10.1007/s10555-021-10004-4 · Cited by 50
Cellular senescence in ischemia/reperfusion injury
Chen, C., Zheng, M., Hou, H., Fang, S., Chen, L., Yang, J., Yao, W., Zhang, Q., & Hei, Z. (2022) · Cell Death Discovery · doi:10.1038/s41420-022-01205-z · Cited by 44
Metabolic regulation by p53: Implications for cancer therapy
Koo, K. Y., Moon, K., He, S., & Lee, M.-S. (2025) · Molecules and Cells · doi:10.1016/j.mocell.2025.100198 · Cited by 48
Tackling cuproptosis: from metabolic rewiring to therapeutic exploitation in cancer
Hao, Q., Gan, Y., & Zhou, X. (2026) · Cellular and Molecular Immunology · doi:10.1038/s41423-026-01387-x · Cited by 48
miRNA interventions serve as ‘magic bullets’ in the reversal of glioblastoma hallmarks
Chen, L., & Kang, C. (2015) · Oncotarget · doi:10.18632/oncotarget.5926 · Cited by 42
“The loss-of-function mutation of TP53 results in the inability to stop further cell-cycle progression triggered by oncogenic signals [61].”
BackgroundAnti‐Tumor Effects of Cardiac Glycosides on Human Lung Cancer Cells and Lung Tumorspheres
Kaushik, V., Yakisich, J. S., Azad, N., Kulkarni, Y., Venkatadri, R., Wright, C. A., Rojanasakul, Y., & Iyer, A. K. V. (2016) · Journal of Cellular Physiology · doi:10.1002/jcp.25611 · Cited by 40
“Such challenges have prompted the evaluation of novel drugs that may be able to concomitantly target multiple mechanisms of lung cancer progression for sustained tumor regression (Kulkarni et al., 2016).”
BackgroundWang, Y., Zhang, C., Jin, Y., Wang, He, Q., Liu, Z., Ai, Q., Lei, Y., Li, Y., Song, F., et al. (2017) · Scientific Reports · doi:10.1038/srep44573 · Cited by 43
Ribosomopathy-like properties of murine and human cancers
Kulkarni, S., Dolezal, J. M., Wang, H., Jackson, L. E., Lu, J. L., Frodey, B. P., Dosunmu-Ogunbi, A. M., Li, Y., Fromherz, M., Kang, A., et al. (2017) · PLoS ONE · doi:10.1371/journal.pone.0182705 · Cited by 41
OrfX, a Nucleomodulin Required for Listeria monocytogenes Virulence
Prokop, A., Gouin, E., Villiers, V., Nahori, M., Vincentelli, R., Duval, M., Cossart, P., & Dussurget, O. (2017) · mBio · doi:10.1128/mbio.01550-17 · Cited by 55
“However, RybP regulates p53, which has been shown to be involved in the regulation of intracellular ROS and RNS levels (67, 68).”
BackgroundA Novel Indolizine Derivative Induces Apoptosis Through the Mitochondria p53 Pathway in HepG2 Cells
Liu, Y., Shao, E., Zhang, Z., Yang, D., Li, G., Cao, H., & Huang, H. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.00762 · Cited by 40
“It has been documented that p53 regulates the expression of different members of the Bcl-2 family proteins such as the antiapoptotic Bcl-2 protein and the pro-apoptotic Bax protein, thus promoting mitochondria-mediated apoptosis (Dashzeveg and Yoshida, 2015; Kruiswijk et al., 2015).”
BackgroundThe metabolic adaptation mechanism of metastatic organotropism
Wang, C., & Luo, D. (2021) · Experimental Hematology and Oncology · doi:10.1186/s40164-021-00223-4 · Cited by 44
“P53 can inhibit glycolysis, enhance OXPHOS and resist oxidative stress [32].”
BackgroundMalic enzyme 2 maintains protein stability of mutant p53 through 2-hydroxyglutarate
Zhao, M., Yao, P., Mao, Y., Wu, J., Wang, W., Geng, C., Cheng, J., Du, W., & Jiang, P. (2022) · Nature Metabolism · doi:10.1038/s42255-022-00532-w · Cited by 43
Advances in the study of acetaminophen-induced liver injury
Li, X., Ni, J., & Chen, L. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1239395 · Cited by 45
“However, when DNA damage is severe, or ROS levels are incredibly high, cells are permanently killed by p53-mediated cell death (Kruiswijk et al., 2015).”
BackgroundA glycolysis-related gene expression signature in predicting recurrence of breast cancer
Tang, J., Luo, Y., & Wu, G. (2020) · Aging · doi:10.18632/aging.103806 · Cited by 39
“Wild type TP53 inhibits the expression of glucose transporters and glycolytic enzymes, thereby suppressing glycolysis [13, 14].”
BackgroundOtub1 stabilizes MDMX and promotes its proapoptotic function at the mitochondria
Chen, Y., Wang, Y.-G., Li, Y., Sun, X., & Dai, M. (2016) · Oncotarget · doi:10.18632/oncotarget.14278 · Cited by 38
Tyurina, Y. Y., Shrivastava, I. H., Tyurin, V. A., Mao, G., Dar, H. H., Watkins, S. C., Epperly, M. W., Bahar, İ., Shvedova, A. A., Pitt, B. R., et al. (2017) · Antioxidants and Redox Signaling · doi:10.1089/ars.2017.7124 · Cited by 40
“However, the failure of the cell to cope with the accumulating damage and (geno)toxicity via activation of repair processes, including DNA repair, necessitates the next elimination step—initiation of apoptosis, commonly via activation of p53-dependent mechanisms operating via mitochondria-dependent pathways (10, 85).”
BackgroundProgress and challenges in Mesothelioma: From bench to bedside
Blyth, K. G., & Murphy, D. J. (2017) · Respiratory Medicine · doi:10.1016/j.rmed.2017.11.015 · Cited by 46
Impairing energy metabolism in solid tumors through agents targeting oncogenic signaling pathways
Fumarola, C., Petronini, P. G., & Alfieri, R. R. (2018) · Biochemical Pharmacology · doi:10.1016/j.bcp.2018.03.006 · Cited by 41
Eiger/TNFα-mediated Dilp8 and ROS production coordinate intra-organ growth in Drosophila
Sanchez, J. A., Mesquita, D., Ingaramo, M. C., Ariel, F., Milán, M., & Dekanty, A. (2019) · PLoS Genetics · doi:10.1371/journal.pgen.1008133 · Cited by 40
The nuclear phosphoinositide response to stress
Chen, M., Wen, T., Horn, H. T., Chandrahas, V. K., Thapa, N., Choi, S., Cryns, V. L., & Anderson, R. A. (2020) · Cell Cycle · doi:10.1080/15384101.2019.1711316 · Cited by 41
“Under genotoxic or oxidative stress, nuclear PIPKIα binds to p53, leading to the production and association of PtdIns(4,5)P2 with the C-terminal PBR of p53 [25], and this sequence is known to regulate many p53 functions [25,143,144,146].”
BackgroundTumor associated macrophages in the molecular pathogenesis of ovarian cancer
Yousefzadeh, Y., Hallaj, S., Moornani, M. B., Asghary, A., Azizi, G., Hojjat‐Farsangi, M., Ghalamfarsa, G., & Jadidi‐Niaragh, F. (2020) · International Immunopharmacology · doi:10.1016/j.intimp.2020.106471 · Cited by 38
Deng, S., Wang, M., Wang, C., Zeng, Y., Qin, X. Y., Tan, Y., Liang, B., & Cao, Y. (2022) · Molecular Biology Reports · doi:10.1007/s11033-022-08047-z · Cited by 44
“As the guardian of the genome, TP53 has evolved to contribute to the regulation of almost every facet of cell behavior, including proliferation, growth, DNA repair, cell death, and cell survival [6].”
BackgroundChen, H. Y., Swaroop, M., Papal, S., Mondal, A. K., Song, H. B., Campello, L., Tawa, G. J., Régent, F., Shimada, H., Nagashima, K., et al. (2023) · eLife · doi:10.7554/elife.83205 · Cited by 43
“The p53 protein acts as a sensor of stress conditions and can act both as a transcriptional activator or repressor to promote cell death and cell survival decisions (Kruiswijk et al., 2015; Liu et al., 2021; Wylie et al., 2022).”
BackgroundCellular senescence as a therapeutic target to improve renal transplantation outcome
van Willigenburg, H., de Keizer, P. L. J., & de Bruin, R. W. F. (2018) · Pharmacological Research · doi:10.1016/j.phrs.2018.02.015 · Cited by 38
Lack of p53 Augments Antitumor Functions in Cytolytic T Cells
Banerjee, A., Thyagarajan, K., Chatterjee, S., Chakraborty, P., Kesarwani, P., Soloshchenko, M., Al-Hommrani, M., Andrijauskaite, K., Moxley, K., Janakiraman, H., et al. (2016) · Cancer Research · doi:10.1158/0008-5472.can-15-1798 · Cited by 38
“Recent studies have shown that p53 is also involved in regulating various metabolic pathways (18), by balancing glycolysis and oxidative phosphorylation, limiting the production of ROS.”
BackgroundLowe, J. M., Nguyen, T., Grimm, S. A., Gabor, K. A., Peddada, S. D., Li, L., Anderson, C. W., Resnick, M. A., Menéndez, D., & Fessler, M. B. (2016) · Cell Death and Differentiation · doi:10.1038/cdd.2016.130 · Cited by 38
“sis, all of which may contribute to the tumor suppressing functions of p53.(11,12) Additional noncanonical tumor-”
BackgroundMPI depletion enhances O-GlcNAcylation of p53 and suppresses the Warburg effect
Shtraizent, N., DeRossi, C., Nayar, S., Sachidanandam, R., Katz, L. S., Prince, A., Koh, A. P., Vincek, A. S., Hadas, Y., Hoshida, Y., et al. (2017) · eLife · doi:10.7554/elife.22477 · Cited by 41
“Due to this vital role in cell survival, regulation of glycolysis and Warburg metabolism requires careful orchestration by survival factors, metabolic enzymes, and metabolic intermediates themselves, via rate-limiting enzymatic steps, post-translational modifications and transcriptional changes (Bensaad et al., 2006;…”
BackgroundInfluentialRole of p53 in Regulating Radiation Responses
Okazaki, R. (2022) · Life · doi:10.3390/life12071099 · Cited by 46
Hall, A. E., Lu, W.-T., Godfrey, J. D., Antonov, A. V., Paicu, C., Moxon, S., Dalmay, T., Wilczynska, A., Muller, P. A. J., & Bushell, M. (2016) · Cell Death and Disease · doi:10.1038/cddis.2016.91 · Cited by 43
“The DNA damage response pathway (DDR) involves a cascade of eventswith multiple effector components, key to which is the tumour suppressor protein p53.(8) DNA damage leads to stabilisation of p53 resulting from the degradation of its ubiquitin ligase, MDM2.”
BackgroundComprehensive analysis of regulation of DNA methyltransferase isoforms in human breast tumors
Hegde, M., & Joshi, M. B. (2021) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-021-03519-4 · Cited by 40
“In response to cellular stress, TP53 regulates expression of target genes thereby inducing cell cycle arrest, programmed cell death, senescence, DNA repair and metabolic changes (Hager and Gu 2014; Kang et al. 2015; Kruiswijk et al. 2015).”
Backgroundp53 regulated senescence mechanism and role of its modulators in age-related disorders
Pawge, G., & Khatik, G. L. (2021) · Biochemical Pharmacology · doi:10.1016/j.bcp.2021.114651 · Cited by 44
p53 regulates autophagic activity in senescent rat mesenchymal stromal cells
Zheng, Y., Lei, Y., Hu, C., & Hu, C. (2016) · Experimental Gerontology · doi:10.1016/j.exger.2016.01.004 · Cited by 37
Kong, Y., Wu, M., Wan, X., Sun, M., Zhang, Y., Wu, Z., Li, C., Liang, X., Gao, L., Ma, C., et al. (2023) · Redox Biology · doi:10.1016/j.redox.2023.102732 · Cited by 37
Mirzayans, R., & Murray, D. L. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241411534 · Cited by 39
Carbone, M., Amelio, I., Affar, E. B., Brugarolas, J., Cannon‐Albright, L., Cantley, L. C., Cavenee, W. K., Chen, Z. J., Croce, C. M., D’Andrea, A. D., et al. (2018) · Cell Death and Differentiation · doi:10.1038/s41418-018-0213-5 · Cited by 39
Wu, C., Dai, Y., Yuan, G., Su, J., & Liu, X. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00869 · Cited by 39
“Notably, the cell cycle pathway was also enriched and, combined with the enrichment of the DNA replication pathway of GSEA KEGG analysis, we conjectured that DNA replication activates the P53 pathway, causing macrophage apoptosis (38, 48).”
BackgroundHashimoto, N., Nagano, H., & Tanaka, T. (2019) · Endocrine Journal · doi:10.1507/endocrj.ej18-0565 · Cited by 41
Uddin, M. A., & Barabutis, N. (2020) · DNA repair · doi:10.1016/j.dnarep.2020.102952 · Cited by 38
“Besides those functions, the lungs support immunological integrity [5, 10-13].”
Sestrin family – the stem controlling healthy ageing
Haidurov, A., & Budanov, A. V. (2020) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2020.111379 · Cited by 39
“p53 might also eliminate stem cells with unrepairable DNA-damage through induction of cell death or senescence (Kruiswijk et al., 2015), preventing carcinogenesis.”
BackgroundLaron Syndrome Research Paves the Way for New Insights in Oncological Investigation
Werner, H., Sarfstein, R., Nagaraj, K., & Laron, Z. (2020) · Cells · doi:10.3390/cells9112446 · Cited by 36
“Accumulation of mutations constitutes an early event in malignant transformation and may lead to the establishment of a tumor [95].”
BackgroundAgarwal, E., Goldman, A. R., Tang, H., Kossenkov, A. V., Ghosh, J. C., Languino, L. R., Vaira, V., Speicher, D. W., & Altieri, D. C. (2021) · Science Advances · doi:10.1126/sciadv.abg7287 · Cited by 36
“Like Parkin, stress-regulated stabilization of p53 also suppresses mitochondrial dynamics (49), increases ROS (50), and triggers metabolic unbalance (51) via inhibition of glycolysis (52) and the PPP (53).”
BackgroundLncPSCA in the 8q24.3 risk locus drives gastric cancer through destabilizing DDX5
Zheng, Y., Lei, T., Jin, G., Guo, H., Zhang, N., Chai, J., Xie, M., Xu, Y., Wang, T., Liu, J., et al. (2021) · EMBO Reports · doi:10.15252/embr.202152707 · Cited by 37
“The P53 signaling serves as one of the most crucial tumor suppressive pathways in the development and progression of multiple malignancies (Kruiswijk et al , 2015; Cheok & Lane, 2017).”
p53-driven lipidome influences non-cell-autonomous lysophospholipids in pancreatic cancer
Butera, A., Roy, M. K., Zampieri, C., Mammarella, E., Panatta, E., Melino, G., D’Alessandro, A., & Amelio, I. (2022) · Biology Direct · doi:10.1186/s13062-022-00319-9 · Cited by 35
Recent Advances in Nanomaterials for the Treatment of Acute Kidney Injury
Ba, X., Ye, T., Shang, H., Tong, Y., Huang, Q., He, Y., Wu, J., Deng, W., Zhong, Z., Yang, X., et al. (2024) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.3c19308 · Cited by 39
mda-7/IL-24 Induces Cell Death in Neuroblastoma through a Novel Mechanism Involving AIF and ATM
Bhoopathi, P., Lee, N., Pradhan, A. K., Shen, X., Das, S. K., Sarkar, D., Emdad, L., & Fisher, P. B. (2016) · Cancer Research · doi:10.1158/0008-5472.can-15-2959 · Cited by 34
Park, S., Lee, J., Kim, Y. H., Park, J., Shin, J., & Nam, S. (2016) · Scientific Reports · doi:10.1038/srep34822 · Cited by 42
miRNA in tumour metabolism and why could it be the preferred pathway for energy reprograming
Alamoudi, A. A., Alnoury, A., & Gad, H. (2017) · Briefings in Functional Genomics · doi:10.1093/bfgp/elx023 · Cited by 37
The Basally Expressed p53-Mediated Homeostatic Function
Nagpal, I., & Yuan, Z.-M. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.775312 · Cited by 35
“M1 macrophages are pro-inflammatory that is characterized by the release of inflammatory cytokines [IL1β, IL-12, IL-6, and tumor necrosis factor (TNF)], reactive oxygen species (ROS), and nitrogen species, whereas M2 macrophages, in contrast, participate in the antiinflammatory response to facilitate wound healing and…”
BackgroundInfluentialCzaplińska, D., Ialchina, R., Andersen, H. B., Yao, J., Stigliani, A., Dannesboe, J., Flinck, M., Chen, X., Mitrega, J., Gnosa, S. P., et al. (2022) · International Journal of Cancer · doi:10.1002/ijc.34367 · Cited by 37
“Acidic pH has been suggested to increase DNA damage(12) and p53 signaling plays a key role in DNA damage protection.(3) Despite this, the cellular level of F IGURE 5 TGFβ signaling is upregulated in acid adapted Panc02 cells and regulates WT Ctrl.”
BackgroundImmunosurveillance encounters cancer metabolism
Chuang, Y., Tzeng, S., Ho, P., & Tsai, C. (2024) · EMBO Reports · doi:10.1038/s44319-023-00038-w · Cited by 34
“In addition to oncogenic mutations, p53, a common tumor suppressor gene, is often mutated or deleted in approximately 50% of human cancers, which leads to aberrant metabolic reprogramming in cancer cells (Kruiswijk et al, 2015).”
BackgroundKemp, M. G., & Sancar, A. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.719740 · Cited by 37
“ATR Promotes Cell Death in a p53-independent Manner— The tumor suppressor protein p53 has numerous functions in response to DNA damage, including in the regulation of apoptosis (77).”
BackgroundChiyoda, T., Hart, P. C., Eckert, M. A., McGregor, S. M., Lastra, R. R., Hamamoto, R., Nakamura, Y., Yamada, S. D., Olopade, O. I., Lengyel, E. R., et al. (2017) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-16-0281 · Cited by 36
“The p53 mutation in the immortalized IOSE and fallopian tube cells could alter metabolism (25); therefore, nonimmortalized primary human FTECs and FTSCs were also tested.”
BackgroundThe role of hypernitrosylation in the pathogenesis and pathophysiology of neuroprogressive diseases
Morris, G., Walder, K. R., Carvalho, A. F., Tye, S. J., Lucas, K., Berk, M., & Maes, M. H. J. (2017) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2017.07.017 · Cited by 33
“However, p53 family proteins also exert a number of other functions in cells including stimulating oxidative phosphorylation while inhibiting glycolysis and influencing lipid metabolism, glutamine metabolism, antioxidant defences and the cellular redox balance (Kruiswijk et al., 2015; Liang et al., 2013; Puzio-Kuter,…”
From Colitis to Cancer: An Evolutionary Trajectory That Merges Maths and Biology
Bakir, I. A., Curtius, K., & Graham, T. A. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02368 · Cited by 35
“TP53 plays a critical role in inducing cell cycle arrest, senescence or apoptosis in cells with damaged genomes, as well as in cells exposed to severe metabolic and oxidative stressors (102) typically generated by severe IBD flares.”
BackgroundVidimar, V., Licona, C., Cerón‐Camacho, R., Guérin, É., Coliat, P., Venkatasamy, A., Ali, M., Guénot, D., Lagadec, R. L., Jung, A. C., et al. (2018) · Cancer Letters · doi:10.1016/j.canlet.2018.09.029 · Cited by 38
Lessons from cavin-1 deficiency
Liu, L. (2020) · Biochemical Society Transactions · doi:10.1042/bst20190380 · Cited by 33
“As a wellknown master regulator, p53 plays significant roles in cell senescence, growth arrest, and apoptosis (reviewed in [72,73]), which are also the common characteristics that can be observed in lipodystrophy and muscular dystrophy.”
BackgroundD’Afonseca, V., Arencibia, A. D., Echeverría-Vega, A., Cerpa, L. C., Cayún, J. P., Varela, N., Salazar, M., & Quiñones, L. A. (2020) · Cancer Informatics · doi:10.1177/1176935120922154 · Cited by 33
Metadata
- Authors
- Kruiswijk, F., Labuschagne, C. F., & Vousden, K. H.
- Affiliations
- Cancer Research UK Scotland Institute (GB)
- Corresponding author
- Vousden, Karen H.
- Venue
- Nature Reviews Molecular Cell Biology
- Published
- 2015-06-23
- Volume
- 16
- Issue
- 7
- Pages
- 393-405
- ISSN
- 1471-0072 (ISSN-L)
- 1471-0080
- OpenAlex
- W1890766043
- Cited by
- 1,080
- References
- 177
- Citations by year
- 2026: 37 · 2025: 54 · 2024: 67 · 2023: 119 · 2022: 133 · 2021: 148 · 2020: 108 · 2019: 104 · 2018: 110 · 2017: 101 · 2016: 84 · 2015: 15
- FWCI
- 11.10
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Reviews Molecular Cell Biology (publishedVersion)
- PubMed (publishedVersion)
- ENLIGHTEN (Jurnal Bimbingan dan Konseling Islam) (submittedVersion)
- Funders
- Cancer Research UK (C596/A10419, 18274)
- Topics
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Keywords
- p53, tumour suppressor, cell survival, cell death, glycolysis, oxidative phosphorylation, reactive oxygen species, cancer metabolism, tumor progression
- MeSH terms
- Animals, Cell Survival, Humans, Tumor Suppressor Protein p53, Cell Death
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.